Advitech announces new efficacy results for Dermylex and compliance with FDA regulations on claims
Advitech Inc. announced that a post-marketing study conducted on patients suffering from psoriasis shows that the use of Dermylex(TM) may benefit patients already using topical corticosteroids. Using Dermylex(TM) with topical corticosteroids may create a synergistic effect and improve overall treatment efficacy results. Therefore, Dermylex(TM) might act as an adjuvant to topical corticosteroids.
"This new data provides Advitech and its commercial partners with important information on treatment strategies and alternatives. Adding Dermylex(TM) to a topical corticosteroid treatment appears to reduce psoriasis severity," stated Dr. Christina Juneau, Advitech's Vice-President of Research and Development. "Advitech will continue to gather and monitor additional data and results from this post-marketing study in order to develop therapeutic strategies for Dermylex(TM) users."
These observations arise from a study by Advitech in which Dermylex(TM) users were invited to provide their own evaluation and comment on the results obtained with Dermylex(TM) whether taken alone or part of a concomitant treatment for psoriasis. In the questionnaire, psoriasis severity was quantified by means of an intensity scale.
Organizations
Other news from the department research and development

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Bone degradation process within metastatic breast cancer identified
New technique multiplies life span in simple organisms

Final report analytica 2012: Decision-makers announce definite intentions to invest - Live Labs generate a great deal of interest
Category:Medical_Council_of_India
Juvenile_idiopathic_arthritis
Woolly_hair_syndrome
Nomad Bioscience: new plant biotechnology company founded to focus on biomaterials and biopharmaceuticals
Usher_syndrome
Jawaharlal_Institute_of_Postgraduate_Medical_Education_&_Research
Phenytoin
Waardenburg_syndrome
